Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Coronary Artery Bypass | 10 | 2020 | 515 | 1.530 |
Why?
|
| Blood Transfusion, Autologous | 1 | 2025 | 35 | 0.880 |
Why?
|
| Preoperative Care | 4 | 2017 | 358 | 0.700 |
Why?
|
| Hemoglobin, Sickle | 4 | 2010 | 18 | 0.700 |
Why?
|
| Postoperative Complications | 6 | 2025 | 3147 | 0.660 |
Why?
|
| Heart Aneurysm | 2 | 2012 | 27 | 0.650 |
Why?
|
| Aspirin | 3 | 2017 | 211 | 0.650 |
Why?
|
| Proteins | 4 | 2010 | 1006 | 0.610 |
Why?
|
| Leukemia | 2 | 2022 | 387 | 0.590 |
Why?
|
| Solutions | 6 | 2010 | 50 | 0.520 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2025 | 699 | 0.500 |
Why?
|
| Coronary Vessels | 2 | 2020 | 521 | 0.500 |
Why?
|
| Syndrome | 2 | 2022 | 1155 | 0.500 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2016 | 102 | 0.480 |
Why?
|
| Coronary Artery Disease | 3 | 2020 | 887 | 0.460 |
Why?
|
| Cardiopulmonary Bypass | 3 | 2013 | 361 | 0.420 |
Why?
|
| Models, Genetic | 1 | 2016 | 749 | 0.400 |
Why?
|
| Protein Conformation | 4 | 2010 | 732 | 0.390 |
Why?
|
| Exercise | 2 | 2022 | 892 | 0.390 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 819 | 0.380 |
Why?
|
| Cognition | 1 | 2018 | 829 | 0.380 |
Why?
|
| Heme | 2 | 2010 | 46 | 0.380 |
Why?
|
| Sodium | 1 | 2013 | 280 | 0.370 |
Why?
|
| Renal Insufficiency | 3 | 2010 | 259 | 0.370 |
Why?
|
| Heart Atria | 2 | 2012 | 343 | 0.360 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2012 | 42 | 0.350 |
Why?
|
| Multiprotein Complexes | 2 | 2010 | 195 | 0.340 |
Why?
|
| Models, Chemical | 3 | 2009 | 78 | 0.310 |
Why?
|
| Genetic Variation | 1 | 2016 | 1559 | 0.310 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2022 | 1168 | 0.300 |
Why?
|
| Crystallization | 4 | 2023 | 83 | 0.300 |
Why?
|
| Viscoelastic Substances | 1 | 2009 | 2 | 0.290 |
Why?
|
| Intraoperative Complications | 1 | 2010 | 154 | 0.280 |
Why?
|
| Cardiotonic Agents | 1 | 2010 | 138 | 0.280 |
Why?
|
| Vasodilator Agents | 1 | 2010 | 197 | 0.280 |
Why?
|
| Catheterization, Peripheral | 1 | 2009 | 118 | 0.270 |
Why?
|
| Pulmonary Veins | 1 | 2009 | 167 | 0.260 |
Why?
|
| Obesity | 3 | 2009 | 2426 | 0.260 |
Why?
|
| Heart Ventricles | 1 | 2012 | 749 | 0.260 |
Why?
|
| Scattering, Radiation | 5 | 2010 | 52 | 0.250 |
Why?
|
| Biophysics | 1 | 2006 | 47 | 0.250 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2017 | 267 | 0.230 |
Why?
|
| Kinetics | 6 | 2010 | 1088 | 0.230 |
Why?
|
| Stroke | 1 | 2013 | 1061 | 0.230 |
Why?
|
| Thermodynamics | 4 | 2010 | 147 | 0.230 |
Why?
|
| Hypertension, Pulmonary | 1 | 2010 | 457 | 0.220 |
Why?
|
| Diabetes Complications | 1 | 2006 | 197 | 0.210 |
Why?
|
| Aged | 11 | 2025 | 21025 | 0.200 |
Why?
|
| Retrospective Studies | 12 | 2025 | 17753 | 0.200 |
Why?
|
| Antimalarials | 1 | 2023 | 40 | 0.190 |
Why?
|
| Humans | 27 | 2025 | 131163 | 0.190 |
Why?
|
| Models, Molecular | 2 | 2007 | 1064 | 0.190 |
Why?
|
| Malaria | 1 | 2023 | 93 | 0.190 |
Why?
|
| Treatment Outcome | 9 | 2025 | 12936 | 0.190 |
Why?
|
| Quinolines | 1 | 2023 | 118 | 0.180 |
Why?
|
| Male | 15 | 2025 | 64957 | 0.170 |
Why?
|
| Nerve Block | 1 | 2022 | 69 | 0.170 |
Why?
|
| Fatigue | 2 | 2022 | 191 | 0.170 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2015 | 246 | 0.170 |
Why?
|
| Heart-Assist Devices | 1 | 2009 | 1020 | 0.160 |
Why?
|
| Light | 4 | 2009 | 166 | 0.160 |
Why?
|
| Propensity Score | 2 | 2020 | 271 | 0.160 |
Why?
|
| Cardioplegic Solutions | 1 | 2020 | 18 | 0.160 |
Why?
|
| Risk Factors | 7 | 2025 | 11074 | 0.160 |
Why?
|
| Databases, Factual | 1 | 2025 | 1240 | 0.150 |
Why?
|
| Heart Arrest, Induced | 1 | 2020 | 75 | 0.150 |
Why?
|
| Middle Aged | 10 | 2025 | 28601 | 0.150 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 1618 | 0.140 |
Why?
|
| Computer Simulation | 2 | 2016 | 674 | 0.140 |
Why?
|
| Female | 14 | 2025 | 70963 | 0.140 |
Why?
|
| Nausea | 1 | 2018 | 83 | 0.140 |
Why?
|
| Drug Administration Schedule | 2 | 2017 | 732 | 0.140 |
Why?
|
| Ultrasonography, Interventional | 2 | 2022 | 205 | 0.140 |
Why?
|
| Time Factors | 6 | 2017 | 6196 | 0.140 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2020 | 222 | 0.140 |
Why?
|
| Phase Transition | 2 | 2010 | 15 | 0.140 |
Why?
|
| Algorithms | 3 | 2016 | 1680 | 0.130 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2017 | 744 | 0.130 |
Why?
|
| Heart Failure | 1 | 2010 | 2332 | 0.120 |
Why?
|
| Sleep Wake Disorders | 1 | 2018 | 204 | 0.120 |
Why?
|
| Cohort Studies | 4 | 2020 | 5063 | 0.120 |
Why?
|
| Pain | 1 | 2018 | 450 | 0.110 |
Why?
|
| Depressive Disorder | 1 | 2018 | 460 | 0.110 |
Why?
|
| Cause of Death | 1 | 2017 | 506 | 0.110 |
Why?
|
| Atrial Appendage | 1 | 2015 | 77 | 0.110 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 1490 | 0.100 |
Why?
|
| Survival Rate | 2 | 2017 | 2114 | 0.100 |
Why?
|
| Intraoperative Period | 1 | 2013 | 63 | 0.100 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2013 | 41 | 0.100 |
Why?
|
| Endarterectomy, Carotid | 1 | 2013 | 75 | 0.090 |
Why?
|
| Texas | 3 | 2017 | 3686 | 0.090 |
Why?
|
| Cerebrovascular Disorders | 1 | 2013 | 111 | 0.090 |
Why?
|
| Exome | 1 | 2016 | 1061 | 0.090 |
Why?
|
| Quality of Life | 1 | 2022 | 2082 | 0.090 |
Why?
|
| Perfusion | 1 | 2013 | 209 | 0.090 |
Why?
|
| Hypothermia, Induced | 1 | 2013 | 172 | 0.090 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 889 | 0.090 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2012 | 214 | 0.080 |
Why?
|
| Cardiac Catheterization | 1 | 2015 | 630 | 0.080 |
Why?
|
| Reoperation | 2 | 2013 | 818 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 5196 | 0.080 |
Why?
|
| Temperature | 2 | 2010 | 291 | 0.080 |
Why?
|
| Protein Multimerization | 1 | 2010 | 148 | 0.080 |
Why?
|
| Depression | 1 | 2018 | 1320 | 0.080 |
Why?
|
| Protein Folding | 1 | 2010 | 214 | 0.070 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2009 | 113 | 0.070 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 1833 | 0.070 |
Why?
|
| Child, Preschool | 3 | 2022 | 15110 | 0.070 |
Why?
|
| Muramidase | 1 | 2009 | 37 | 0.070 |
Why?
|
| Viscosity | 1 | 2009 | 38 | 0.070 |
Why?
|
| Serum Albumin, Bovine | 1 | 2009 | 37 | 0.070 |
Why?
|
| Hematoma | 1 | 2009 | 85 | 0.070 |
Why?
|
| Prognosis | 2 | 2020 | 4886 | 0.070 |
Why?
|
| Cardiac Output, Low | 1 | 2009 | 58 | 0.070 |
Why?
|
| Elasticity | 1 | 2009 | 97 | 0.070 |
Why?
|
| Risk Assessment | 3 | 2013 | 3711 | 0.070 |
Why?
|
| Cytosol | 1 | 2009 | 135 | 0.070 |
Why?
|
| Thrombectomy | 1 | 2009 | 117 | 0.070 |
Why?
|
| Multienzyme Complexes | 2 | 2007 | 76 | 0.070 |
Why?
|
| Aorta, Thoracic | 1 | 2013 | 530 | 0.070 |
Why?
|
| Vascular Surgical Procedures | 1 | 2013 | 534 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 2833 | 0.070 |
Why?
|
| Atrial Fibrillation | 1 | 2015 | 738 | 0.070 |
Why?
|
| Ultrasonography | 1 | 2012 | 943 | 0.070 |
Why?
|
| Logistic Models | 4 | 2015 | 1797 | 0.060 |
Why?
|
| Phenotype | 1 | 2016 | 4497 | 0.060 |
Why?
|
| Adolescent | 3 | 2022 | 20987 | 0.060 |
Why?
|
| Molecular Conformation | 1 | 2006 | 96 | 0.060 |
Why?
|
| Length of Stay | 2 | 2009 | 1421 | 0.060 |
Why?
|
| Polymers | 1 | 2006 | 103 | 0.060 |
Why?
|
| Postoperative Period | 2 | 2020 | 331 | 0.060 |
Why?
|
| Hemoglobins | 1 | 2006 | 286 | 0.060 |
Why?
|
| Morbidity | 1 | 2006 | 256 | 0.060 |
Why?
|
| Dimerization | 1 | 2005 | 137 | 0.060 |
Why?
|
| Thrombosis | 1 | 2009 | 499 | 0.050 |
Why?
|
| Child | 3 | 2022 | 26341 | 0.050 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2009 | 425 | 0.050 |
Why?
|
| Inpatients | 1 | 2009 | 562 | 0.050 |
Why?
|
| Artemisinins | 1 | 2023 | 8 | 0.050 |
Why?
|
| Hemin | 1 | 2023 | 14 | 0.050 |
Why?
|
| Hemeproteins | 1 | 2023 | 8 | 0.050 |
Why?
|
| Odds Ratio | 3 | 2012 | 1211 | 0.050 |
Why?
|
| Hospital Mortality | 3 | 2013 | 1064 | 0.050 |
Why?
|
| Metabolic Syndrome | 1 | 2006 | 369 | 0.040 |
Why?
|
| Myocardial Infarction | 1 | 2009 | 999 | 0.040 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 1378 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2013 | 563 | 0.040 |
Why?
|
| Erythrocytes | 2 | 2010 | 186 | 0.030 |
Why?
|
| Adult | 3 | 2022 | 31282 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 546 | 0.030 |
Why?
|
| Recurrence | 1 | 2020 | 1489 | 0.030 |
Why?
|
| Ligation | 1 | 2015 | 134 | 0.030 |
Why?
|
| Radiography, Interventional | 1 | 2015 | 79 | 0.030 |
Why?
|
| Mutation | 1 | 2006 | 6099 | 0.020 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2020 | 895 | 0.020 |
Why?
|
| Renal Dialysis | 2 | 2010 | 951 | 0.020 |
Why?
|
| Linear Models | 1 | 2013 | 688 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2010 | 3061 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 2013 | 294 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2010 | 92 | 0.020 |
Why?
|
| Heart Valves | 1 | 2010 | 52 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2020 | 6459 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2013 | 487 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 2304 | 0.020 |
Why?
|
| Perioperative Care | 1 | 2010 | 217 | 0.020 |
Why?
|
| Chemistry, Physical | 1 | 2007 | 25 | 0.020 |
Why?
|
| Chemical Phenomena | 1 | 2007 | 46 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 2007 | 130 | 0.020 |
Why?
|
| Bacillus subtilis | 1 | 2007 | 42 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 2007 | 98 | 0.020 |
Why?
|
| Enzyme Stability | 1 | 2005 | 58 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 6797 | 0.010 |
Why?
|
| Incidence | 1 | 2012 | 3360 | 0.010 |
Why?
|
| Anemia, Sickle Cell | 1 | 2007 | 334 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2009 | 1717 | 0.010 |
Why?
|